Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Connect Biopharma Holdings (CNTB) FCF Margin (2024 - 2025)

Connect Biopharma Holdings' FCF Margin history spans 2 years, with the latest figure at 109000.0% for Q3 2025.

  • For Q3 2025, FCF Margin fell 10792092.0% year-over-year to 109000.0%; the TTM value through Sep 2025 reached 5698.46%, down 391585.0%, while the annual FY2024 figure was 2.88%, N/A changed from the prior year.
  • FCF Margin for Q3 2025 was 109000.0% at Connect Biopharma Holdings, down from 44.84% in the prior quarter.
  • Across five years, FCF Margin topped out at 44.84% in Q4 2024 and bottomed at 109000.0% in Q3 2025.